Press release
Human Insulin Market Size Worth USD 21.92 Billion in 2032 | Emergen Research
Human Insulin Market
Market Drivers
Diabetes, the fastest-growing chronic disease worldwide, has seen a steady rise in prevalence over the years, with an estimated 537 million adults affected globally in 2021, according to the World Health Organization (WHO). Moreover, the aging population, expected to double over the next three decades, further contributes to the escalating demand for human insulins.
Technological advancements, notably in recombinant DNA technology and the integration of Artificial Intelligence (AI) into production systems, are also driving market growth. These innovations enhance productivity, energy efficiency, and sustainability, consequently improving customer experience.
To Receive A PDF Sample Of The Report, Visit @https://www.emergenresearch.com/request-sample/2843
Continuous Glucose Monitoring (CGM) devices and insulin pumps represent additional technical breakthroughs revolutionizing insulin therapy. CGM devices enable real-time glucose monitoring, offering valuable insights for effective diabetes management. Similarly, insulin pumps provide precise insulin delivery, enhancing glycemic control and patient convenience.
Market Restraints
The certain factors pose challenges to market growth. Limitations in skilled workforce, high manufacturing expenses, and stringent government regulations may hinder revenue expansion. The considerable costs associated with insulin production equipment and the scarcity of proficient professionals in the field present affordability and operational constraints for manufacturers.
The global human insulin market is segmented based on product, application, and end-use. The dominance of the long-acting insulin segment is attributed to its sustained efficacy and patent protection, accounting for the largest market share in 2022. Biosimilar insulins are anticipated to register moderate growth, driven by their potential to improve patient compliance and reduce drug costs.
In terms of application, the type 1 diabetes segment is expected to hold a significant market share due to the high insulin dependency of type 1 patients, characterized as a more severe condition compared to type 2 diabetes. Conversely, the type 2 diabetes segment is projected to exhibit steady growth, fueled by the rising prevalence of the disease.
Additionally, ongoing Research & Development (R&D) efforts focus on oral insulin delivery systems, offering an alternative to insulin injections. Currently, only two systems have received FDA approval, with ORMD-0801 undergoing phase 3 clinical trials. The approval of such products presents patients with additional treatment options and enhances accessibility to insulin therapy.
To Get A Discount On The Latest Report, Visit @https://www.emergenresearch.com/request-discount/2843
In terms of end-use, the retail pharmacy segment is anticipated to dominate the market, driven by the increased accessibility of treatment options and medications. Patients find it easier to access prescribed medications and related products at local pharmacies, driving demand for these services.
Overall, the global human insulin market is on a trajectory of significant growth, propelled by the escalating prevalence of diabetes, technological advancements, and expanding treatment options. Despite challenges, the market is poised to witness substantial expansion in the coming years.
Human Insulin Top Companies and Competitive Landscape
The global human insulin market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective human insulin solutions.
• Tonghua Dongbao Pharmaceutical Co., Ltd.
• Eli Lilly and Company
• Biocon Ltd.
• Merck & Co., Inc.
• Ypsomed AG
• Johnson & Johnson Private Limited
• Albireo Pharma, Inc.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• WOCKHARDT
Human Insulin Latest Industry News
• In November 2022, Biocon Sdn. Bhd., a subsidiary of Biocon based in Malaysia, disclosed the acquisition of a three-year contract for its recombinant human insulin brand, Insugen, awarded by the Ministry of Health (MoH) in Malaysia.
Browse Detailed Research Report @https://www.emergenresearch.com/industry-report/human-insulin-market
Human Insulin Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global human insulin market on the basis of product, application, type, end-use, and region:
• Product Outlook (Revenue, USD Billion; 2019-2032)
o Rapid acting insulin
o Long acting insulin
o Combination insulin
o Biosimilar insulin
o Others
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Type 1
o Type 2
• Type Outlook (Revenue, USD Billion; 2019-2032)
o Analog insulin
o Human insulin
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospital & clinics
o Retail pharmacy
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of Middle East & Africa
Buy Now: @https://www.emergenresearch.com/select-license/2843
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Insulin Market Size Worth USD 21.92 Billion in 2032 | Emergen Research here
News-ID: 3472164 • Views: …
More Releases from Emergen Research
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Publi …
The global Bacteriophage Market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth.
Bacteriophages have been shown to be…
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and…
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the…
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion…
More Releases for Human
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
The Human Whisperer
'The Human Whisperer'
Finlay McArthur
Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version.
The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and…
Human Physiology 2019
Human Physiology 2019
Theme: Exploring the Principles of Physiology & Metabolism
September 16-17, 2019 | London, United Kingdom
Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build…
Building A Better Human: The Future Of Human Augmentation
Market Scenario:
Human augmentation is usually used to denote technologies that enhance human efficiency or capability, that in some way add to the human body. Technological advancements in many areas of IT have directed to a greater variety of implants and other technologies that can be classed as human augmentation.Human augmentation may also be named human 2.0. Within the greater group of human augmentation technologies, some diverse classifications can be made.…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
